Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma

Improved therapies for individuals with head and neck squamous cell carcinoma (HNSCC) may be developed by identification of appropriate biomarkers. The aim of this study was to evaluate the usefulness of serum midkine measurement as a biomarker for HNSCC. Pretreatment serum midkine concentrations we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Taku, Shimada, Hideaki, Tanaka, Shingo, Araki, Koji, Tomifuji, Masayuki, Mizokami, Daisuke, Tanaka, Nobuaki, Kamide, Daisuke, Miyagawa, Yoshihiro, Suzuki, Hiroshi, Tanaka, Yuya, Shiotani, Akihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799940/
https://www.ncbi.nlm.nih.gov/pubmed/26798989
http://dx.doi.org/10.1002/cam4.600

Ejemplares similares

Ejemplares similares